– Showcases Allplex™ HPV merchandise designed to check for 14 high-risk HPV genotypes
– Advocates HPV testing for early prognosis and prevention of cervical most cancers
– Goals to speed up the widespread adoption of syndromic PCR testing to create “a world free from all ailments”
SEOUL, South Korea, July 16, 2024 /PRNewswire/ — Seegene Inc. (KQ096530), a number one South Korean firm offering a complete resolution for PCR molecular diagnostics, demonstrated its human papillomavirus (HPV) diagnostic merchandise and underscored the vital significance of HPV screening check on the Asia-Oceania Analysis Group in Genital An infection and Neoplasia (AOGIN) convention, held in Seoul, South Korea from July 11-13.
On the AOGIN, Seegene offered its superior applied sciences for figuring out viruses linked to cervical most cancers. The corporate organized an exhibition sales space and hosted a symposium session beneath the theme of ‘Navigating scientific tips and implementations for HPV cervical most cancers screening.’
The corporate showcased its distinctive quantitative PCR technology-based HPV diagnostic merchandise, ‘Allplex™ HPV HR Detection’ and ‘Allplex™ HPV28 Detection’. The Allplex™ HPV HR Detection is designed to check for 14 high-risk HPVs, together with sorts 16 and 18, in a single tube. The Allplex™ HPV28 Detection is designed to check for 28 HPVs, in two tubes, together with 19 high-risk sorts and 9 low-risk sorts, in two tubes. The merchandise are perfect for cervical most cancers prevention and follow-up administration.
The corporate additionally launched Seegene’s STARlet-AIOS™, a completely automated molecular diagnostic testing system that streamlines your complete PCR course of from nucleic acid extraction to outcome evaluation, together with SG STATS, the corporate’s premium platform of superior statistical evaluation.
On the symposium session hosted by Seegene on July 11, Dr. Lan Xu from the Shanghai Jiao Tong College of Public Well being in China offered a lecture on “Scientific validation of human papillomavirus assays for cervical most cancers screening through the VALGENT framework.” Dr. Shin-Wha Lee from the Asan Medical Middle and College of Ulsan in Korea confirmed her research on “Incorporating HPV testing with genotypes in population-based screening packages.”
“At AOGIN, we had been capable of showcase the excellence of Seegene’s PCR testing know-how and HPV merchandise. We count on our HPV merchandise to be adopted in cervical most cancers screening packages in additional nations,” stated Daniel Shin, Govt Vice-President and Chief International Gross sales and Advertising Officer at Seegene. “We’re at the moment working a marketing campaign within the international market to boost consciousness about the advantages of syndromic PCR testing, together with simultaneous testing for HPV and sexually transmitted infections (STIs). We consider the marketing campaign will pave the way in which for the widespread adoption of syndromic PCR testing, serving to to comprehend “a world free from all ailments.”
Seegene’s syndromic quantitative PCR know-how is simultaneous multiplex molecular diagnostic know-how primarily based on real-time PCR. It permits for the detection of assorted pathogens inflicting related signs in a single tube, facilitating quick and correct prognosis. Moreover, analyzing the cycle threshold (Ct) worth helps decide the extent of the an infection, which reinforces medical observe. Seegene is the primary to globally commercialize ‘3 Ct’ know-how, which may present the Ct worth of three targets in a single channel.
Cervical most cancers is the fourth most typical most cancers amongst girls worldwide, with the second-highest mortality charge. In accordance with the World Well being Group (WHO), roughly 600,000 girls are newly identified with cervical most cancers annually globally, leading to 340,000 deaths. Within the Asia-Pacific area alone, about 270,000 girls are identified yearly, with over 140,000 deaths reported. The WHO has set a goal to realize 70% cervical most cancers screening protection by 2030, a big improve from the present 20%. In 2020, solely 33% of girls had been screened for cervical most cancers no less than as soon as.
There are about 200 HPV genotypes, of which 99.8% of cervical cancers are brought on by HPV. Sorts 16 and 18 account for 70% of cervical most cancers, whereas 19 high-risk sorts are answerable for 90% of all most cancers instances. The development to most cancers relies on the genotype of the HPV an infection, the extent of the an infection and co-infection. Since most HPV infections don’t current clear signs, correct detection is vital for the early prognosis of cervical most cancers. Not too long ago, many nations have been recommending HPV testing as an alternative of the Pap smear for cervical most cancers screening.
About Seegene
Seegene has 23 years of devoted R&D, manufacturing, and enterprise expertise round syndromic quantitative PCR applied sciences, which was highlighted through the COVID-19 pandemic when it supplied over 340 million COVID-19 checks to greater than 100 nations worldwide. The core function of Seegene’s distinctive syndromic PCR applied sciences is the power to concurrently check 14 pathogens that trigger related signs in a single tube and supply quantitative info on the infectivity profile to correlate with the severity of sickness.
About AOGIN 2024
The AOGIN, based in 2004, includes of 25 member nations in Asia and Oceania. The group hosts worldwide educational conferences centered on the remedy and prevention of cervical most cancers. This yr’s convention in Seoul attracted over 500 consultants from 22 nations, together with China, Japan, and India, who shared the newest analysis findings and scientific practices concerning HPV.
Brand – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg
